245 related articles for article (PubMed ID: 10334521)
1. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer.
Tortola S; Marcuello E; González I; Reyes G; Arribas R; Aiza G; Sancho FJ; Peinado MA; Capella G
J Clin Oncol; 1999 May; 17(5):1375-81. PubMed ID: 10334521
[TBL] [Abstract][Full Text] [Related]
2. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
3. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
5. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations, acetylator status, and prognosis in colorectal cancer.
Hardingham JE; Butler WJ; Roder D; Dobrovic A; Dymock RB; Sage RE; Roberts-Thomson IC
Gut; 1998 May; 42(5):669-72. PubMed ID: 9659162
[TBL] [Abstract][Full Text] [Related]
7. Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.
Schiller JH; Adak S; Feins RH; Keller SM; Fry WA; Livingston RB; Hammond ME; Wolf B; Sabatini L; Jett J; Kohman L; Johnson DH
J Clin Oncol; 2001 Jan; 19(2):448-57. PubMed ID: 11208838
[TBL] [Abstract][Full Text] [Related]
8. Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer.
Samowitz WS; Holden JA; Curtin K; Edwards SL; Walker AR; Lin HA; Robertson MA; Nichols MF; Gruenthal KM; Lynch BJ; Leppert MF; Slattery ML
Am J Pathol; 2001 Apr; 158(4):1517-24. PubMed ID: 11290569
[TBL] [Abstract][Full Text] [Related]
9. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of p53, K-ras, and BRAF genes in colorectal cancer progression.
Calistri D; Rengucci C; Seymour I; Lattuneddu A; Polifemo AM; Monti F; Saragoni L; Amadori D
J Cell Physiol; 2005 Aug; 204(2):484-8. PubMed ID: 15702478
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
13. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous mutations in K-ras and TP53 are indicative of poor prognosis in sporadic colorectal cancer.
González-Aguilera JJ; Oliart S; Azcoita MM; Fernández-Peralta AM
Am J Clin Oncol; 2004 Feb; 27(1):39-45. PubMed ID: 14758132
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.
Wang JY; Hsieh JS; Chang MY; Huang TJ; Chen FM; Cheng TL; Alexandersen K; Huang YS; Tzou WS; Lin SR
World J Surg; 2004 Jul; 28(7):721-6. PubMed ID: 15185002
[TBL] [Abstract][Full Text] [Related]
16. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.
Huang CL; Taki T; Adachi M; Konishi T; Higashiyama M; Kinoshita M; Hadama T; Miyake M
Int J Oncol; 1998 Mar; 12(3):553-63. PubMed ID: 9472092
[TBL] [Abstract][Full Text] [Related]
17. K-ras and p16 aberrations confer poor prognosis in human colorectal cancer.
Esteller M; González S; Risques RA; Marcuello E; Mangues R; Germà JR; Herman JG; Capellà G; Peinado MA
J Clin Oncol; 2001 Jan; 19(2):299-304. PubMed ID: 11208819
[TBL] [Abstract][Full Text] [Related]
18. K-ras and p53 gene mutations in colorectal cancer in 57 Japanese patients.
Onda M; Abe R; Tsuchiya A; Fukushima T; Ando Y; Yoshida T
Fukushima J Med Sci; 1997 Jun; 43(1):29-39. PubMed ID: 9431782
[TBL] [Abstract][Full Text] [Related]
19. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.
Löhr M; Müller P; Mora J; Brinkmann B; Ostwald C; Farré A; Lluis F; Adam U; Stubbe J; Plath F; Nizze H; Hopt UT; Barten M; Capellá G; Liebe S
Gastrointest Endosc; 2001 Jun; 53(7):734-43. PubMed ID: 11375580
[TBL] [Abstract][Full Text] [Related]
20. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
